June 2017 Briefing – Pathology
Here are what the editors at HealthDay consider to be the most important developments in Pathology for June 2017. This roundup includes the latest...
Genetic, Environmental Exposure Tied to Islet Autoantibodies
Link for male sex; father, sibling as diabetic proband; weight at 12 months with insulin autoantibodies
In HIV, Greater BMD Decline for Immediate Versus Delayed ART
After one year, change in bone mineral density was similar in the immediate and deferred groups
Nanoallergen Platform Can Identify Immunogenic Epitopes
Novel platform can identify immunogenic epitopes in major peanut allergy protein, Ara h2
Genes Responsible for Crohn’s, Ulcerative Colitis Identified
Findings could improve efficacy of current treatments, lead to discovery of new drug targets
Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels
T1DM Patients With Active β-Cell Function Differ Immunologically
Findings for patients with remaining endogenous β-cell function after 10 or more years of T1DM
Health of the Nation Presented in 40th Annual CDC Report
Report includes trends of data for past 40 years, with increase in life expectancy, drop in infant mortality
Higher IQ in Childhood Associated With a Longer Life
Lifestyle choices may explain why children with a higher IQ tend to outlive their peers
Melanoma Diagnoses Can Vary Widely Among Pathologists
Potential for both overdiagnosis and underdiagnosis, patient confusion
